(ARQQ) Arqit Quantum - Overview
Exchange: NASDAQ •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: KYG0567U1013
Stock: QuantumCloud, Encryption, Satellite, Terrestrial, Cybersecurity
Total Rating 8
Risk 35
Buy Signal -0.30
| Risk 5d forecast | |
|---|---|
| Volatility | 153% |
| Relative Tail Risk | -14.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.50 |
| Alpha | -37.54 |
| Character TTM | |
|---|---|
| Beta | 2.286 |
| Beta Downside | 1.504 |
| Drawdowns 3y | |
|---|---|
| Max DD | 94.75% |
| CAGR/Max DD | -0.34 |
Description: ARQQ Arqit Quantum December 27, 2025
Arqit Quantum Inc. (NASDAQ: ARQQ) delivers quantum-enhanced cybersecurity solutions from its London base, operating both satellite-based and terrestrial networks. Its flagship offering, QuantumCloud, is a Platform-as-Service that generates “unbreakable” encryption keys using quantum key distribution (QKD), and the firm also sells maintenance, support, and professional services around this technology.
Key industry signals that could affect ARQQ’s outlook include: (1) the global quantum-safe encryption market, projected by IDC to grow at a CAGR of roughly 30 % through 2028, driven by rising regulatory pressure on data protection; (2) the UK government’s £1 billion “Quantum Technologies” investment programme, of which a portion is earmarked for secure communications and may fund pilot deployments; and (3) ARQQ’s recent Q2 2024 financial disclosure showing a 45 % YoY increase in contracted revenue, albeit with a cash burn rate of $12 M per quarter, indicating a need for additional capital to scale.
For a deeper dive into ARQQ’s valuation metrics, you might explore ValueRay’s analyst toolkit.
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income: -89.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -1.55 > 0.02 and ΔFCF/TA 11.98 > 1.0 |
| NWC/Revenue: 2719 % < 20% (prev 1645 %; Δ 1074 % < -1%) |
| CFO/TA -1.47 > 3% & CFO -63.0m > Net Income -89.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.69 > 1.5 & < 3 |
| Outstanding Shares: last fiscal year (13.8m) vs prev 172.5% < -2% |
| Gross Margin: -138.5% > 18% (prev -1.75%; Δ -13.7k% > 0.5%) |
| Asset Turnover: 2.66% > 50% (prev 2.62%; Δ 0.04% > 0%) |
| Interest Coverage Ratio: -226.6 > 6 (EBITDA TTM -57.1m / Interest Expense TTM 271.0k) |
Altman Z'' -15.00
| A: 0.59 (Total Current Assets 40.0m - Total Current Liabilities 14.9m) / Total Assets 42.9m |
| B: -8.72 (Retained Earnings -373.8m / Total Assets 42.9m) |
| C: -1.77 (EBIT TTM -61.4m / Avg Total Assets 34.8m) |
| D: -11.48 (Book Value of Equity -179.2m / Total Liabilities 15.6m) |
| Altman-Z'' Score: -48.51 = D |
Beneish M -0.43
| DSRI: 4.89 (Receivables 3.04m/471.0k, Revenue 924.0k/699.5k) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.68 (AQ_t 0.05 / AQ_t-1 0.07) |
| SGI: 1.32 (Revenue 924.0k / 699.5k) |
| TATA: -0.63 (NI -89.9m - CFO -63.0m) / TA 42.9m) |
| Beneish M-Score: -0.43 (Cap -4..+1) = D |
What is the price of ARQQ shares?
As of February 08, 2026, the stock is trading at USD 18.59 with a total of 460,460 shares traded.
Over the past week, the price has changed by -8.51%, over one month by -32.72%, over three months by -41.85% and over the past year by -7.56%.
Over the past week, the price has changed by -8.51%, over one month by -32.72%, over three months by -41.85% and over the past year by -7.56%.
Is ARQQ a buy, sell or hold?
Arqit Quantum has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy ARQQ.
- StrongBuy: 0
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the ARQQ price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 60 | 222.8% |
| Analysts Target Price | 60 | 222.8% |
| ValueRay Target Price | 15.1 | -18.8% |
ARQQ Fundamental Data Overview February 04, 2026
P/E Forward = 18.7266
P/S = 595.6566
P/B = 11.6774
Revenue TTM = 924.0k USD
EBIT TTM = -61.4m USD
EBITDA TTM = -57.1m USD
Long Term Debt = 719.0k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 530.0k USD (from shortTermDebt, last quarter)
Debt = 719.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -36.3m USD (from netDebt column, last quarter)
Enterprise Value = 279.4m USD (315.7m + Debt 719.0k - CCE 37.0m)
Interest Coverage Ratio = -226.6 (Ebit TTM -61.4m / Interest Expense TTM 271.0k)
EV/FCF = -4.21x (Enterprise Value 279.4m / FCF TTM -66.4m)
FCF Yield = -23.75% (FCF TTM -66.4m / Enterprise Value 279.4m)
FCF Margin = -7183 % (FCF TTM -66.4m / Revenue TTM 924.0k)
Net Margin = -9732 % (Net Income TTM -89.9m / Revenue TTM 924.0k)
Gross Margin = -138.5% ((Revenue TTM 924.0k - Cost of Revenue TTM 2.20m) / Revenue TTM)
Gross Margin QoQ = 30.89% (prev none%)
Tobins Q-Ratio = 6.52 (Enterprise Value 279.4m / Total Assets 42.9m)
Interest Expense / Debt = 3.06% (Interest Expense 22.0k / Debt 719.0k)
Taxrate = 21.0% (US default 21%)
NOPAT = -48.5m (EBIT -61.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.69 (Total Current Assets 40.0m / Total Current Liabilities 14.9m)
Debt / Equity = 0.03 (Debt 719.0k / totalStockholderEquity, last quarter 27.2m)
Debt / EBITDA = 0.64 (negative EBITDA) (Net Debt -36.3m / EBITDA -57.1m)
Debt / FCF = 0.55 (negative FCF - burning cash) (Net Debt -36.3m / FCF TTM -66.4m)
Total Stockholder Equity = 17.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -258.5% (out of range, set to none)
RoE = -506.5% (Net Income TTM -89.9m / Total Stockholder Equity 17.8m)
RoCE = -332.5% (out of range, set to none) (EBIT -61.4m / Capital Employed (Equity 17.8m + L.T.Debt 719.0k))
RoIC = -264.5% (out of range, set to none) (NOPAT -48.5m / Invested Capital 18.3m)
WACC = 14.31% (E(315.7m)/V(316.4m) * Re(14.34%) + D(719.0k)/V(316.4m) * Rd(3.06%) * (1-Tc(0.21)))
Discount Rate = 14.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 53.50%
Fair Price DCF = unknown (Cash Flow -66.4m)
EPS Correlation: -18.12 | EPS CAGR: -34.59% | SUE: -1.06 | # QB: 0
Revenue Correlation: 33.74 | Revenue CAGR: 238.1% | SUE: -0.00 | # QB: 0
EPS current Year (2026-09-30): EPS=-1.52 | Chg30d=+0.130 | Revisions Net=+1 | Growth EPS=+29.8% | Growth Revenue=+368.3%
EPS next Year (2027-09-30): EPS=-1.06 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+30.3% | Growth Revenue=+214.2%
P/S = 595.6566
P/B = 11.6774
Revenue TTM = 924.0k USD
EBIT TTM = -61.4m USD
EBITDA TTM = -57.1m USD
Long Term Debt = 719.0k USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 530.0k USD (from shortTermDebt, last quarter)
Debt = 719.0k USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -36.3m USD (from netDebt column, last quarter)
Enterprise Value = 279.4m USD (315.7m + Debt 719.0k - CCE 37.0m)
Interest Coverage Ratio = -226.6 (Ebit TTM -61.4m / Interest Expense TTM 271.0k)
EV/FCF = -4.21x (Enterprise Value 279.4m / FCF TTM -66.4m)
FCF Yield = -23.75% (FCF TTM -66.4m / Enterprise Value 279.4m)
FCF Margin = -7183 % (FCF TTM -66.4m / Revenue TTM 924.0k)
Net Margin = -9732 % (Net Income TTM -89.9m / Revenue TTM 924.0k)
Gross Margin = -138.5% ((Revenue TTM 924.0k - Cost of Revenue TTM 2.20m) / Revenue TTM)
Gross Margin QoQ = 30.89% (prev none%)
Tobins Q-Ratio = 6.52 (Enterprise Value 279.4m / Total Assets 42.9m)
Interest Expense / Debt = 3.06% (Interest Expense 22.0k / Debt 719.0k)
Taxrate = 21.0% (US default 21%)
NOPAT = -48.5m (EBIT -61.4m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 2.69 (Total Current Assets 40.0m / Total Current Liabilities 14.9m)
Debt / Equity = 0.03 (Debt 719.0k / totalStockholderEquity, last quarter 27.2m)
Debt / EBITDA = 0.64 (negative EBITDA) (Net Debt -36.3m / EBITDA -57.1m)
Debt / FCF = 0.55 (negative FCF - burning cash) (Net Debt -36.3m / FCF TTM -66.4m)
Total Stockholder Equity = 17.8m (last 4 quarters mean from totalStockholderEquity)
RoA = -258.5% (out of range, set to none)
RoE = -506.5% (Net Income TTM -89.9m / Total Stockholder Equity 17.8m)
RoCE = -332.5% (out of range, set to none) (EBIT -61.4m / Capital Employed (Equity 17.8m + L.T.Debt 719.0k))
RoIC = -264.5% (out of range, set to none) (NOPAT -48.5m / Invested Capital 18.3m)
WACC = 14.31% (E(315.7m)/V(316.4m) * Re(14.34%) + D(719.0k)/V(316.4m) * Rd(3.06%) * (1-Tc(0.21)))
Discount Rate = 14.34% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 53.50%
Fair Price DCF = unknown (Cash Flow -66.4m)
EPS Correlation: -18.12 | EPS CAGR: -34.59% | SUE: -1.06 | # QB: 0
Revenue Correlation: 33.74 | Revenue CAGR: 238.1% | SUE: -0.00 | # QB: 0
EPS current Year (2026-09-30): EPS=-1.52 | Chg30d=+0.130 | Revisions Net=+1 | Growth EPS=+29.8% | Growth Revenue=+368.3%
EPS next Year (2027-09-30): EPS=-1.06 | Chg30d=N/A | Revisions Net=+0 | Growth EPS=+30.3% | Growth Revenue=+214.2%